PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PHOSPHORUS METABOLISM”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 757 records · Page 42Linked to original sources

Metabolic bone disorders. Imbalances of calcium and phosphorus.

This article describes the physiology of normal calcium and phosphorus metabolism and the influences of various hormonal agents. Clinical variables affecting the interpretation of calcium are explained. In addition, the effects of calcium and phosphorus excess and deficiency are described according to the nursing model. Two metabolic bone disorders, osteoporosis and renal osteodystrophy, are discussed in order to demonstrate the altered metabolic effects of calcium and phosphorus.

Bone Diseases, Metabolic↗

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy.

Brain phosphorus metabolism was measured in 22 patients with depressive disorders. Ten of them had DSM-III-R bipolar disorder, and 12 had major depression. In bipolar patients, phosphomonoester (PME) and intracellular pH were significantly increased in the depressive state than in the euthymic state, while those values in the euthymic state were significantly low as compared to age-matched normal controls. Phosphocreatine (PCr) was significantly decreased in severely depressed patients compared to mild depressives. These findings suggest that high energy phosphate metabolism, intracellular pH and membrane phospholipid metabolism are altered in depressive disorders.

Adenosine Triphosphate↗

Parathyroid function and vitamin D metabolism during human growth hormone replacement.

Changes in calcium and phosphorus metabolism were studied in nine children with GH deficiency before and during human GH replacement therapy. Parathyroid function and serum concentrations of physiologically important vitamin D metabolites were examined to determine their relationship to changes in mineral metabolism. By comparison with pretreatment values, the GH-treated children showed significant increases in growth rate and renal tubular phosphate reabsorption and a significant decrease in urinary calcium excretion after a standardized oral load. There was no significant change in serum concentrations of parathyroid hormone, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or 24,25-dihydroxyvitamin D or in nephrogenous cAMP excretion. Although GH has been proposed as a regulator of vitamin D metabolism, the present study demonstrates that the anabolic changes in calcium and phosphorus metabolism accompanying GH therapy are not mediated via changes in parathyroid hormone or vitamin D status.

Adolescent↗

[The eye manifestations in phosphorus-calcium metabolic disorders].

The investigation of a number of 286 patients having disorders of binocular seeing shows a very frequent association of these to spasmophilia, especially for persons of feminine sex during their third or fourth decades of life. The medicamentous treatment of spasmophilia has ameliorated the disturbing binocular seeings, which had appeared again after stopping the treatment for a long time. The authors recommend the cover-test end the examination using Maddox's experiment for tracing rapidly out the binocular seeing disturbings. In order to stimulate the movements of the ocular globe in an reverse sense to the deviation formed by the oculomotor existed lack of poise, it had been used the prescription of classes with prisms assembled conversely to the classic rules, having the indication of wearing them for 3-4 hours a day.

Adolescent↗

[Phosphorus-calcium metabolism and dietetic correction of its disorders in chronic kidney diseases in children].

Ninety children with varying renal diseases were under observation. The investigations conducted have shown that disorders in phosphoric-calcium metabolism depend on the type, activity of chronic glomerulonephritis (CGN) and etiology of chronic renal insufficiency (CRI). Significant disorders in phosphoric-calcium metabolism were detected in patients with nephrotic and mixed types of CGN. Most manifest clinical and x-ray changes of the osseous system were observed in patients with CRI that developed as a result of the tubulointerstitial pathologic process. Low-phosphate diets with preset amounts of Ca and P were developed, composed of products with relatively low content of P, and of new dietetic products rich in Ca. The diets were used for correction of hyperphosphatemia in children with CGN and in those with CRI, simultaneously with drug therapy, to prevent or diminish disorders in phosphoric-calcium metabolism, and to reduce the risk of invalidism among children with chronic renal diseases.

Calcium↗

[The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].

Correction of impaired phosphoric-calcium metabolism was performed in 15 hemodialysis patients with terminal chronic renal failure (TCRF). For this purpose a synthetic analogue of pyrophosphoric acid xidiphone produced in Russia was used (2% aqueous solution 1 tablespoon 3 times a day 0.5 h before meal for 2-3 months). Prior to and in the course of xidiphone treatment all the patients received calcium gluconate (1 g x 3 daily), polyvitamins, on-demand digoxine. Measurements of serum concentrations of urea, potassium, sodium, total calcium, alkaline phosphatase activity demonstrated xidiphone-related normalization of serum total calcium, serum activity of alkaline phosphatase, a mild rise of sodium. The results say in favor of using xidiphone in the TCRF patients.

Adult↗

Effects of pH on enhanced biological phosphorus removal metabolisms.

Laboratory-scale sequencing batch reactors exhibiting enhanced biological phosphorus removal were analyzed for pH effects on anaerobic phosphorus (P) release, glycogen degradation, and acetate uptake. Samples with non-soluble P/total suspended solids values of either 0.13-0.14 mg/mg (HP) or 0.065-0.075 mg/mg (LP) were analyzed in anaerobic batch tests with excess acetate addition at pH values ranging from 5.2 to 9.5. A polyphosphate-accumulating metabolism (PAM) had a competitive advantage over a glycogen-accumulating metabolism (GAM) at pH > 7.0. Maximum acetate uptake rates by the HP and LP samples occurred at pH values 8.0 and 6.9, respectively. Anaerobic P release/acetate uptake increased with increasing pH at rates similar to previously reported values. Glycogen degradation/acetate uptake decreased with increasing pH above pH 7, which disagreed with previous reports that glycogen degradation/acetate increased or was unaffected by increasing pH. The results suggested that the acetate uptake mechanisms of GAM and PAM may be different.

Acetates↗